NCT01588522 2025-05-28
Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced Alopecia
BPGbio
Phase 1 Completed
Clinical Trials
12 trialsNCT03469271 2023-09-26
Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients
Mayo Clinic
Phase 4 Completed
NCT01293682 2022-04-20
Effects of High Dose Calcitriol in Breast Cancer Patients
University of Rochester
Phase 2 Completed
NCT03261336 2021-02-08
Oral Calcitriol With Ketoconazole in CRPC
Inova Health Care Services
Phase 2 Terminated
NCT01317940 2020-07-08
Nutrition and Body Composition in Acute Lymphoblastic Leukemia
Children's Hospital Los Angeles
Phase 2 Completed
NCT00301067 2019-06-04
Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma
Northwestern University
Phase 1/2 Completed
NCT00904033 2019-04-23
Calcitriol, Physical Activity, and Bone Health in Cancer Survivors
University of Rochester
Phase 2 Completed
NCT00690924 2018-06-04
Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer
Roswell Park Cancer Institute
Phase NA Completed
NCT00794547 2017-12-12
Phase I/II Calcitriol in Lung Cancer
University of Michigan Rogel Cancer Center
Phase 1/2 Terminated
NCT00524589 2017-11-20
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00536991 2017-06-14
Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer
Roswell Park Cancer Institute
Phase 1/2 Terminated
NCT00427804 2013-02-04
Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption
Atlanta VA Medical Center
Phase NA Completed